Data for this study contain potentially identifying or sensitive patient information. Therefore, it would be available upon reasonable request from the Ethics Committee of Xiangya School of Public Health of Central South University (<csugwxy@126.com>).

Introduction {#sec005}
============

Ageing is a severe problem in China as well as throughout the world. According to the data of the Sixth National Population Census in 2010, the number of people in China aged 60 years and above was approximately 177 million, accounting for 13.26% of the total population \[[@pone.0232834.ref001]\]. The United Nations (UN) Commission on Population Development predicted that by 2020 the elderly population aged 60 and above in China would reach 243.8 million, accounting for 17.1% of the total population \[[@pone.0232834.ref002]\]. Sleep problems have become the most common complaints among the elderly. Approximately 74% of the elderly men and 79% of the elderly women reported sleep complaints in Italy \[[@pone.0232834.ref003]\]. In addition, previous studies reported that the prevalence of sleep disorders was approximately 30--40% among older residents \[[@pone.0232834.ref004],[@pone.0232834.ref005]\]. However, as a complicated phenomenon, the sleep quality of individuals is difficult to define and assess objectively. Using a standardized assessment tool for sleep quality, the Pittsburgh Sleep Quality Index (PSQI), epidemiological studies indicated that the self-rated prevalence of poor sleep quality was 62.4% among older adults in Thailand \[[@pone.0232834.ref006]\], 16.6% among Mexican Americans aged 75 and older \[[@pone.0232834.ref007]\], 41.5% and 33.8% among the elderly adults living in urban and rural areas of China, respectively \[[@pone.0232834.ref008],[@pone.0232834.ref009]\]. However, several studies demonstrated that most sleep problems may be exacerbated by institutional settings \[[@pone.0232834.ref010],[@pone.0232834.ref011]\]. For instance, a study conducted on 100 selected individuals of over 65 years of age found that institutionalized elderly people presented more worse overall sleep quality and higher levels of daytime somnolence than non-institutionalized elderly people \[[@pone.0232834.ref010]\]. Fetveit and colleagues \[[@pone.0232834.ref011]\] found that the prevalence of sleep disturbance was approximately 70% among nursing home residents. In summary, sleep problems are very common among the elderly and pose a major challenge to public health.

Evidence is emerging that poor sleep quality is positively associated with physical health, mental disorders and quality of life \[[@pone.0232834.ref012],[@pone.0232834.ref013]\]. For example, a large cohort study found that poor sleep quality was associated with higher odds of hypertension among a Chinese rural population \[[@pone.0232834.ref013]\]. Another large cohort study indicated that short sleepers with poor sleep quality had an increased risk of cardiovascular disease \[[@pone.0232834.ref014]\]. In addition, many studies \[[@pone.0232834.ref015]--[@pone.0232834.ref017]\] have indicated that poor sleep quality is a powerful predictor of suicidal ideation and depressive symptoms among the elderly. However, the underlying mechanisms between poor sleep quality and these harmful consequences are still unclear.

To alleviate the personal suffering and adverse effects introduced by poor sleep quality, it is essential to understand its prevalence pattern and associated factors. Previous studies have demonstrated many factors related to poor sleep quality among older adults, including but not limited to the following four domains: (1) socio-demographic factors, such as age \[[@pone.0232834.ref009]\], marital status \[[@pone.0232834.ref018]\] and education \[[@pone.0232834.ref019]\]; (2) lifestyle factors, such as physical activity \[[@pone.0232834.ref020]\] and caffeine intake \[[@pone.0232834.ref021]\]; (3) emotional factors, such as stress \[[@pone.0232834.ref022]\] and depression \[[@pone.0232834.ref020]\]; and (4) chronic conditions, such as arthritis \[[@pone.0232834.ref009]\] and pulmonary disease \[[@pone.0232834.ref023]\]. However, few studies have examined the prevalence and risk factors of poor sleep quality in a nursing home population. Moreover, no study has explored the interactions of risk factors for poor sleep quality among elderly residents in nursing homes. Thus, the aims of this study were as follows: (1) to find the prevalence of poor sleep quality among the elderly in nursing homes in China; (2) to explore the risk factors for poor sleep quality; and (3) to explore the interactions of risk factors for poor sleep quality.

Materials and methods {#sec006}
=====================

Study population {#sec007}
----------------

This was a cross-sectional study conducted in the nursing homes of Hunan Province in China from October to December 2018. This study was approved by the Ethical Committee of Xiangya School of Public Health in Central South University (No.XYGW-2018-49). Written informed consent was obtained from all participants of this study. In order to select a representative elderly sample living in the nursing homes of Hunan Province, a multistage sampling method was used. First, each city from northern Hunan, southern Hunan and central Hunan was selected (i.e., based on geographical region): Changsha city, Hengyang city and Yiyang city, respectively. Subsequently, one county and two districts were randomly chosen from each selected city. For instance, Changsha County and the districts, Kaifu and Yuelu, were selected from Changsha City; Hengyang County and the districts, Yanfeng and Shigu, were selected from Hengyang City; and Yuanjiang County and the districts, Ziyang and Heshan, were selected from Yiyang City. Second, two townships were randomly chosen from each county. For example, Xingsha and Tiaoma were sampled from Changsha County; Xidu and Jingtou were sampled from Hengyang County; and Qionghu and Caowei were sampled from Yuanjiang County. Finally, two nursing homes were randomly selected from each selected district and township, and a total of 24 nursing homes were ultimately selected.

Residents in the selected nursing homes were included in our study if they met the following inclusion criteria: (1) had age 60 years and above; (2) had duration of entrance into nursing homes of more than one year; and (3) had physical and mental ability to participate in interviews. However, residents in the same homes were excluded if they (1) refused to participate in this study; (2) had a severe hearing impairment or language barrier, and (3) had a history of severe cognitive deficit. In summary, among a total of 2,055 older adults residents in the 24 nursing homes, 511 adults were excluded because they were younger than 60 years old or had stayed in a nursing home less than one year. A total of 603 older adults had a severe hearing impairment, language barrier or severe cognitive deficit, and 112 older adult residents who did not agree to participate were also excluded from this study. Of the remaining 829 older adults, 12 were excluded due to incomplete data. Ultimately, a total of 817 elderly adults were included in the data analysis in this study.

Data measurement {#sec008}
----------------

All data were obtained through face-to-face interviews by trained staff who spent 30 to 60 minutes with each respondent when conducting the interviews. Data on the following variables were collected: socio-demographics (age, gender, education, marital status, monthly individual income, number of descendants, length of stay in a nursing home and medical insurance status), lifestyle behavioural factors (smoking, alcohol drinking and physical exercise), physical status (activities of daily living (ADLs) and number of chronic disease) and social psychological factors (social support, depression symptoms and anxiety symptoms). Furthermore, marital status was dichotomized into stable and unstable, where unstable marital status included divorce, widow/widower and never having been married. Besides, smoking was assessed by a single item and defined as an average of at least one cigarette per day in the last year, and alcohol drinking was also assessed by a single item and defined as drinking a glass of wine per day in the last week. In addition, regular physical exercise was defined as to engage in at least 30 minutes of physical exercise at least three times a week. Moreover, ADL status was assessed using the Chinese version of Lawton and Brody's ADL scale, which subsequently dichotomized participants into disabled and normal \[[@pone.0232834.ref024]\]. Disabled ADL status was determined when participants had a total score of greater than 14 points. Cronbach's α of this instrument was 0.926 in this study. Additionally, self-reported chronic diseases were measured by a multiple choices question, which referred to chronic non-communicable diseases, including hypertension, diabetes, coronary heart disease (CHD), chronic obstructive pulmonary disease (COPD), hyperlipidaemia, stroke and others. Further, social support was measured using the Social Support Rating Scale (SSRS), which was developed by Xiao and is widely used in China. Using this instrument, participants were divided into two groups based on the median of the global scores (low social support: score≤30 points; and high social support: score\>30 points). As regards depression symptoms, they were measured using the Chinese version of the Geriatric Depression Scale-30 items (GDS-30) \[[@pone.0232834.ref025]\]. This instrument has been commonly used in China and has indicated high validity and reliability among the Chinese elderly population\[[@pone.0232834.ref026]\]. Thus, when used on the sample of this study, a Cronbach's α of 0.925 was obtained. The GDS-30 consists of 30 true/false questions, and the total score ranges from 0 to 30 points. In this study, participants had depression symptoms if they scored 11 or more points on this instrument. On the other hand, anxiety symptoms were measured using the Chinese version of the Generalized Anxiety Disorder-7 scale (GAD-7). This instrument is a seven-item self-report instrument, in which each item assesses one of the typical symptoms of GAD over the last two weeks, thus, a total score ranges between 0 and 21. Cronbach's α of this tool was 0.933 in this study. Participants who scored 10 or more were considered to have anxiety symptoms in this study \[[@pone.0232834.ref027]\].

Assessment of sleep quality {#sec009}
---------------------------

Sleep quality among the subjects was assessed using the Chinese version of the Pittsburgh Sleep Quality Index (PSQI) \[[@pone.0232834.ref028]\], which has been proven to have good validity and reliability among older adults \[[@pone.0232834.ref029]\]. The PSQI is a self-rated questionnaire that assesses sleep quality in the past month. It contains nineteen items grouped into seven components: subjective sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Each component score ranges from 0 to 3, and the total score ranges from 0 to 21 points. Participants with a global PSQI score greater than 5 were defined as having poor sleep quality in this study. Cronbach's α for this tool was 0.781 in this study.

Statistical analysis {#sec010}
--------------------

Categorical variables were presented as frequencies and percentages. Continuous variables were presented as the mean±standard deviation (SD). The distribution of continuous variables across subgroups of categorical variables was compared using Student's t-test or one-way analysis of variance (ANOVA). The relationship between categorical variables was analysed using the Pearson chi-square test or the Mantel-Haenszel chi-square test. Multiple binary logistic regression analysis was used to examine risk factors associated with poor sleep quality. The adjusted odds ratios (AORs) and 95% confidence intervals (CIs) were also estimated after controlling for other confounders. Microsoft Excel, developed by Andersson and colleagues \[[@pone.0232834.ref030]\], was used to detect and calculate the additive interaction of risk factors for poor sleep quality. The relative excess risk due to interaction (RERI) and the attributable proportion due to interaction (AP) of equal to 0, or the synergy index (S) of equal to 1, suggested no additive interaction between two factors. A *P*\<0.05 and *P*\<0.025 indicated statistically significant results for groups and multiple comparisons, respectively. All statistical analyses were performed in SAS 9.3 (SAS Institute Inc., Cary, NC, USA).

Results {#sec011}
=======

Characteristics of the study sample {#sec012}
-----------------------------------

In total, 817 elderly residents living in nursing homes were included in this study. Among them, more than half of participants aged 80 years and above. In addition, 54.0% of the subjects were female, and 46.0% were male. Also, approximately 40% of the participants had completed less than 6 years of education, and a similar proportion had stable marriages. Moreover, approximately one-third of the total sample reported monthly individual incomes of more than 3,000 RMB. Also, a small proportion of cigarette smoking (16.2%), alcohol drinking (11.8%), and subjects that had no chronic diseases (24.1%) were observed among the participants. Furthermore, approximately 36.0% of the subjects had depressive symptoms, while 16.0% had anxiety symptoms.

There were statistically significant differences between poor sleepers and good sleepers in age, education, marital status, monthly individual income, length of stay, number of chronic diseases, depression symptoms, anxiety symptoms, social support and ADL status (all *P*\<0.05). Poor sleepers were seemingly those who had older age, lower education, unstable marriages, lower monthly individual incomes, longer lengths of stay, at least one type of chronic disease, depression symptoms, anxiety symptoms, lower social support and disabled ADLs. The results in detail are presented in [Table 1](#pone.0232834.t001){ref-type="table"}.

10.1371/journal.pone.0232834.t001

###### Characteristics of the elderly residents in the nursing homes.

![](pone.0232834.t001){#pone.0232834.t001g}

  Characteristic               Total (n = 817)   Poor sleeper (n = 550)   Good sleeper (n = 267)   *P*-value[^†^](#t001fn002){ref-type="table-fn"}
  ---------------------------- ----------------- ------------------------ ------------------------ -------------------------------------------------
  Age (years)                                                                                      
      60\~                     135(16.5)         73(13.3)                 62(23.2)                 \<0.001
      70\~                     232(28.4)         150(27.3)                82(30.7)                 
      80\~                     450(55.1)         327(59.4)                123(46.1)                
  Gender                                                                                           
      Male                     376(46.0)         251(45.6)                125(46.8)                0.751
      Female                   441(54.0)         299(54.4)                142(53.2)                
  Education (years)                                                                                
      0--6                     364(44.6)         263(47.8)                101(37.8)                0.004
      7\~                      203(24.8)         138(25.1)                65(24.4)                 
      10\~                     250(30.6)         149(27.1)                101(37.8)                
  Marital status                                                                                   
      Stable                   302(37.0)         186(33.8)                116(43.4)                0.007
      Unstable                 515(63.0)         364(66.2)                151(56.6)                
  Medical insurance                                                                                
      Yes                      766(93.8)         517(94.0)                249(93.3)                0.681
      No                       51(6.2)           33(6.0)                  18(6.7)                  
  Monthly individual income                                                                        
      ≤3,000 RMB               568(69.5)         404(73.5)                164(61.4)                \<0.001
      \>3,000 RMB              249(30.5)         146(26.5)                103(38.6)                
  Length of stay (years)                                                                           
      1\~                      444(54.3)         284(51.6)                160(59.9)                0.026
      3\~                      373(45.7)         266(48.4)                107(40.1)                
  Have descendants                                                                                 
      Yes                      746(91.3)         496(90.2)                250(93.6)                0.100
      No                       71(8.7)           54(9.8)                  17(6.4)                  
  Smoking                                                                                          
      Yes                      132(16.2)         82(14.9)                 50(18.7)                 0.164
      No                       685(83.8)         468(85.1)                217(81.3)                
  Alcohol drinking                                                                                 
      Yes                      96(11.8)          60(10.9)                 36(13.5)                 0.284
      No                       721(88.2)         490(89.1)                231(76.5)                
  Physical exercise                                                                                
      Regular                  353(43.2)         233(42.4)                120(44.9)                0.485
      Irregular                464(56.8)         317(57.6)                147(55.1)                
  Number of chronic diseases                                                                       
      0                        197(21.4)         96(17.5)                 101(37.8)                \<0.001
      1\~                      450(55.1)         318(57.8)                132(49.5)                
      3\~                      170(20.8)         136(24.7)                34(12.7)                 
  ADL status                                                                                       
      Normal                   268(32.8)         152(27.6)                116(43.4)                \<0.001
      Disabled                 549(67.2)         398(72.4)                151(56.6)                
  Depression symptoms                                                                              
      Yes                      294(36.0)         251(45.6)                43(16.1)                 \<0.001
      No                       523(64.0)         299(54.4)                224(83.9)                
  Anxiety symptoms                                                                                 
      Yes                      136(16.6)         124(22.5)                12(4.5)                  \<0.001
      No                       681(83.4)         426(77.5)                255(95.5)                
  Social support                                                                                   
      Low                      435(53.2)         337(61.3)                98(36.7)                 \<0.001
      High                     382(46.8)         213(38.7)                169(63.3)                

Data are presented as n (%). ADLs, activities of daily living.

† P-value was determined by the Pearson chi-square test.

Prevalence of poor sleep quality {#sec013}
--------------------------------

The mean global PSQI score was 8.5 points overall (95% CI: 8.2, 8.8), 8.3 points in males (95% CI: 7.8, 8.8) and 8.7 points in females (95% CI: 8.2, 9.1). There was no statistically significant difference in the PSQI score between males and females (*P* = 0.293). The total PSQI score increased with increased age, for example, from 7.4 points (95% CI: 6.6, 8.2) in subjects aged 60--69 to 8.9 points (95% CI: 8.4, 9.3) in subjects aged ≥80 (*P* = 0.010). Additionally, 550 individuals had a total PSQI score of greater than 5, and the overall prevalence of poor sleep quality was 67.3% (95% CI: 64.0%, 70.5%). Nevertheless, the prevalence of poor sleep quality was 66.8% (95% CI: 61.7%, 71.0%) among males and 67.8% (95% CI: 63.5%, 72.1%) among females. The prevalence also increased with increased age, that is, the prevalence increased from 54.1% (95% CI: 45.9%, 63.0%) in participants aged 60--69 years to 72.7% (95% CI: 68.7%, 77.1%) in participants aged ≥80 years (*P* for trend \<0.001). The results are shown in [Table 2](#pone.0232834.t002){ref-type="table"}.

10.1371/journal.pone.0232834.t002

###### The PSQI global score and the prevalence of poor sleep quality among the elderly in the nursing homes stratified by age and gender.
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               N     PSQI score Mean (95% CI)   P-value                                      Poor sleep quality[^†^](#t002fn001){ref-type="table-fn"}Prevalence (95% CI)   P-value
  ------------ ----- -------------------------- -------------------------------------------- ----------------------------------------------------------------------------- ----------------------------------------------
  Total        817   8.5(8.2, 8.8)                                                           67.3(64.0, 70.5)                                                              
  Gender                                                                                                                                                                   
      Male     376   8.3(7.8, 8.8)              0.293                                        66.8(61.7, 71.0)                                                              0.751
      Female   441   8.7(8.2, 9.1)                                                           67.8(63.5, 72.1)                                                              
  Age                                                                                                                                                                      
      60\~     135   7.4(6.6, 8.2)              0.010[\*](#t002fn002){ref-type="table-fn"}   54.1(45.9, 63.0)                                                              \<0.001[\*](#t002fn002){ref-type="table-fn"}
      70\~     232   8.4(7.8, 9.1)                                                           64.7(58.6, 70.5)                                                              
      80\~     450   8.9(8.4, 9.3)                                                           72.7(68.7, 77.1)                                                              

†Poor sleep quality was determined by PSQI score \>5.

\**P*-value for trend.

Components of sleep quality {#sec014}
---------------------------

Most of the participants went to bed at 9 PM and woke up at approximately 6 AM. The average bedtime of the participants was 9.1±3.5 hours, and the average sleep duration was 6.8±3.9 hours. Most subjects could not fall asleep within 30 minutes. The average sleep efficiency of the participants was 80.0%. Approximately 85% of the subjects never used sleep medication. The mean scores for subjective sleep quality, sleep disturbance and daytime dysfunction were 1.3±0.9, 1.2±0.6 and 1.4 ±1.1, respectively.

No statistically significant differences were observed between males and females on all components of sleep quality. More older residents than younger people have used sleep medication. Moreover, older adults have more daytime dysfunction than younger individuals do. No significant differences were obtained in sleep latency, sleep efficiency or sleep disturbance between age groups. The results are shown in [Table 3](#pone.0232834.t003){ref-type="table"}.

10.1371/journal.pone.0232834.t003

###### Gender- and age-specific scores of sleep quality components measured by the Chinese version of the Pittsburgh Sleep Quality Index.
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  Sleep quality components                                                            Total (n = 817)   Gender      Age group (years)                                                
  ------------------------------------------------------------------------- --------- ----------------- ----------- ------------------- ------- ----------- ----------- ------------ ---------
  Subjective sleep quality[^†^](#t003fn002){ref-type="table-fn"}, mean±SD             1.3±0.9           1.3±0.9     1.3±0.9             0.674   1.2±0.9     1.3±0.9     1.3±0.9      0.482
  Sleep latency, n(%)                                                       ≤15 min   236(28.9)         116(30.9)   120(27.2)           0.200   51(37.8)    63(27.2)    122(27.1)    0.161
                                                                            16\~min   252(30.8)         121(32.2)   131(29.7)                   34(25.2)    75(32.3)    143(31.8)    
                                                                            31\~min   329(40.3)         139(36.9)   190(43.1)                   50(37.0)    94(40.5)    185(41.1)    
  Sleep duration, mean±SD                                                             6.8±3.9           6.8±3.1     6.8±4.4             0.908   6.9±2.1     6.7±2.7     6.9±4.7      0.759
  Sleep duration, n(%)                                                      \<6 h     262(32.1)         121(32.2)   141(32.0)           0.253   38(28.1)    80(34.5)    144(32.0)    0.008
                                                                            6--7 h    278(34.0)         118(31.4)   160(36.3)                   38(28.1)    67(28.9)    173(38.4)    
                                                                            \>7 h     277(33.9)         137(36.4)   140(31.7)                   59(43.8)    85(36.6)    133(29.6)    
  Habitual sleep efficiency[\*](#t003fn003){ref-type="table-fn"}, mean±SD             0.8±0.4           0.8±0.3     0.8±0.4             0.593   0.8±0.2     0.7±0.2     0.8±0.5      0.558
  Habitual sleep efficiency, n(%)                                           \<65%     270(33.1)         125(33.2)   145(32.8)           0.803   41(30.4)    80(34.4)    149(33.1)    0.075
                                                                            65--74%   103(12.6)         48(12.8)    55(12.5)                    14(10.4)    28(12.1)    61(13.6)     
                                                                            75--84%   135(16.5)         57(15.2)    78(17.7)                    15(11.1)    34(14.7)    86(19.1)     
                                                                            \>85%     309(37.8)         146(38.8)   163(37.0)                   65(48.1)    90(38.8)    154 (34.2)   
  Sleep disturbances[^‡^](#t003fn004){ref-type="table-fn"}, mean±SD                   1.2±0.6           1.2±0.6     1.2±0.6             0.914   1.2±0.6     1.3±0.6     1.3±0.5      0.148
  Any sleep disturbance, n(%)                                               Yes       248(30.4)         112(29.8)   136(30.8)           0.745   38(28.1)    72(31.0)    138(30.7)    0.826
                                                                            No        569(69.6)         264(60.2)   305(69.2)                   97(71.9)    160(69.0)   312(69.3)    
  Use of sleep medication, n(%)                                             Yes       115(14.1)         44(11.7)    71(16.1)            0.072   9(6.7)      23(9.9)     83(18.4)     \<0.001
                                                                            No        702(85.9)         332(88.3)   370(83.9)                   126(93.3)   209(90.1)   367(81.6)    
  Daytime dysfunction[\*\*](#t003fn005){ref-type="table-fn"}, mean±SD                 1.4±1.1           1.4±1.1     1.5±1.0             0.620   1.2 ±1.0    1.5±1.1     1.5±1.0      0.037

SD, standard deviation.

†Score range 0 to 3; higher scores indicate poor subjective sleep quality

\*Derived from the formula: hours of sleep/(get-up time--usual bedtime)×100%; score range from 0 to 1; higher scores indicate higher sleep efficiency

‡Derived from PSQI items 5b-5j; score range from 0 to 3; higher scores indicate more sleep disturbances

\*\*Derived from PSQI item 8 and 9; score range from 0 to 3; higher scores indicate more daytime dysfunction.

Risk factors for poor sleep quality {#sec015}
-----------------------------------

Multiple binary logistic regression analysis results suggested that having age between 70 and 79 years (AOR: 1.78, 95% CI: 1.08, 2.92) or 80 years and above (AOR: 2.67, 95% CI: 1.68, 4.24) increased the risk of poor sleep quality when compared with age between 60 and 69 years after adjustments were made for other confounding factors. Moreover, participants with one to two kinds of chronic diseases (AOR: 2.05, 95% CI: 1.39, 3.01), three or more kinds of chronic diseases (AOR: 2.35, 95%: 1.39, 4.00), depression symptoms (AOR: 1.08, 95% CI: 1.04, 1.11), anxiety symptoms (AOR: 1.11, 95% CI: 1.05, 1.18) and social support (AOR: 0.97, 95% CI: 0.95, 0.99) were more likely to report poor sleep quality after adjustments were made for other variables. The results are shown in [Table 4](#pone.0232834.t004){ref-type="table"}.

10.1371/journal.pone.0232834.t004

###### Risk factors for poor sleep quality among the elderly in nursing homes.

![](pone.0232834.t004){#pone.0232834.t004g}

  Variable                     B       SE     Wald    AOR(95% CI)[^†^](#t004fn002){ref-type="table-fn"}   P-value
  ---------------------------- ------- ------ ------- --------------------------------------------------- ---------
  Age (years)                                                                                             
      60\~                                            1.00                                                
      70\~                     0.58    0.25   5.15    1.78(1.08, 2.92)                                    0.023
      80\~                     0.98    0.24   17.37   2.67(1.68, 4.24)                                    \<0.001
  Number of chronic diseases                                                                              
      0\~                                             1.00                                                
      1\~                      0.72    0.20   13.31   2.05(1.39, 3.01)                                    \<0.001
      3\~                      0.86    0.27   10.01   2.35(1.39, 4.00)                                    \<0.001
  Depression symptoms          0.07    0.02   17.29   1.08(1.04,1.11)                                     \<0.001
  Anxiety symptoms             0.11    0.03   14.02   1.11(1.05,1.18)                                     \<0.001
  Social support               -0.03   0.01   5.32    0.97(0.95,0.99)                                     0.021

SE, standard error; AOR, adjusted odds ratio.

†Adjusted for gender, education, marital status, smoking, alcohol drinking, physical exercise, descendants, medical insurance, monthly individual income, length of stay and ADL status, as well as the variables in the table.

Interactions of risk factors for poor sleep quality {#sec016}
---------------------------------------------------

The Andersson's Excel was used to detect interactions between risk factors for sleep quality and calculate their effect size on poor sleep quality. Thus, interactions were detected between the following variables: older age and anxiety symptoms, with a RERI of 2.83 (95% CI: 0.13, 5.52), an AP of 0.34 (95% CI: 0.13, 0.55) and an S of 1.63 (95% CI: 1.11, 2.39); chronic disease and anxiety symptoms, with a RERI of 3.32 (95% CI: 0.31, 6.33), an AP of 0.39 (95% CI: 0.29, 0.48) and an S of 1.77 (95% CI: 1.54, 2.04); and social support and anxiety symptoms, with a RERI of 2.96 (95% CI: 1.02, 4.90), an AP of 0.46 (95% CI: 0.38, 0.54) and an S of 2.20 (95% CI: 1.65, 2.93). No statistically significant interactions were found between other factors after adjusting for confounders. The results are shown in [Table 5](#pone.0232834.t005){ref-type="table"}.

10.1371/journal.pone.0232834.t005

###### Interactions between risk factors for poor sleep quality among the elderly in nursing homes.
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  Factor 1          Factor 2           AOR[^†^](#t005fn002){ref-type="table-fn"}   RERI               AP                 S
  ----------------- ------------------ ------------------------------------------- ------------------ ------------------ ------------------
  Age (years)       Anxiety symptoms                                               2.83(0.13, 5.52)   0.34(0.13, 0.55)   1.63(1.11, 2.39)
      60--69        No                 1.00                                                                              
      ≥70           No                 2.09(1.01, 4.32)                                                                  
      60--69        Yes                4.43(2.13, 9.20)                                                                  
      ≥70           Yes                8.34(4.43, 15.69)                                                                 
  Chronic disease   Anxiety symptoms                                               3.32(0.31, 6.33)   0.39(0.29, 0.48)   1.77(1.54, 2.04)
      No            No                 1.00                                                                              
      Yes           No                 2.51(1.92, 3.29)                                                                  
      No            Yes                3.79(1.82, 7.86)                                                                  
      Yes           Yes                8.61(4.28, 17.31)                                                                 
  Social support    Anxiety symptoms                                               2.96(1.02, 4.90)   0.46(0.38, 0.54)   2.20(1.65, 2.93)
      High          No                 1.00                                                                              
      Low           No                 1.61(1.10, 2.35)                                                                  
      High          Yes                2.87(1.38, 5.95)                                                                  
      Low           Yes                6.43(3.22, 12.86)                                                                 

AOR, adjusted odds ratio; RERI, the relative excess risk due to interaction; AP, the attributable proportion due to interaction; S, the synergy index.

†Adjusted for gender, education, marital status, smoking, alcohol drinking, physical exercise, descendants, medical insurance, monthly individual income, length of stay, depression symptoms and ADL status, as well as the variables in the table.

Discussion {#sec017}
==========

This study examined the prevalence of poor sleep quality and its risk factors among the elderly in nursing homes in China. Additionally, interactions of risk factors for poor sleep quality were explored. It was found that poor sleep quality affected nearly two-thirds (67.3%) of the elderly residents in nursing homes of this sample, and those with older age, chronic diseases, depression symptoms, anxiety symptoms and lower social support were the most likely to be affected by poor sleep quality. Moreover, additive interactions were detected between age and anxiety symptoms; and between education and anxiety symptoms.

This large population-based study used a standardized and valid PSQI tool to measure the characteristics of sleep quality among elderly adults in nursing homes in China. Based on this approach, we found that the prevalence of poor sleep quality was 67.3% among elderly residents in nursing homes in China. This finding is comparable to those of other previous studies conducted in elderly adults living in nursing homes in Turkey \[[@pone.0232834.ref031],[@pone.0232834.ref032]\]. However, with a similar population, the same institutional setting and measurement tool, Stefan et al \[[@pone.0232834.ref033]\] found that 54.5% of individuals were poor sleepers among 894 elderly adults in Zagreb nursing homes. Tsai et al \[[@pone.0232834.ref034]\] found that 46.4% of participants reported poor sleep quality among 196 elderly nursing home residents in Taiwan. A reason for the variance in these estimates may be explained by the different inclusion criteria for the study sample, as well as the differences in facilities and medical care among different institutions. As mentioned in the introduction, some sleep problems may be exacerbated by institutional setting. Our study also indicates that the prevalence of poor sleep quality in nursing homes was higher than in community homes. For instance, only 33.8% of community-dwelling elderly adults in Yanggu County \[[@pone.0232834.ref008]\] and 27.7% in Deqing County \[[@pone.0232834.ref035]\] in China reported poor sleep quality. On the one hand, the high self-rated prevalence may result from residents in nursing homes being older (55.1% of participants were aged 80 years and above in this study) and having more chronic conditions (78.5% of participants have at least one kind of chronic disease) than elderly adults in the community \[[@pone.0232834.ref036]\]. On the other hand, an uncomfortable environment and care routines in the institution may not promote sleep \[[@pone.0232834.ref037]\]. Among the seven PSQI components, lower sleep efficiency (62.2%) was the most common, followed by longer sleep latency (40.3%) and sleep disturbances (30.4%). These results were consistent with those of previous studies \[[@pone.0232834.ref031],[@pone.0232834.ref032]\]. As shown in our study, elderly adults suffered from several negative emotions (e.g., depression and anxiety) that may lead to longer sleep latency and lower sleep efficiency \[[@pone.0232834.ref038]\]. The main cause of sleep disturbances in nursing home settings may be nocturia in elderly adults, as well as noise and an uncomfortable environment \[[@pone.0232834.ref039]\]. However, the use of sleep medication was not prevalent in this population, and only 14.1% of individuals reported that they had taken sleep medication in the previous month. These results indicated that sleep problems in residents may not attract enough attention by administrative and healthcare staff in nursing homes. Otherwise, people had no awareness and believed that they were obtaining healthcare services for sleep problems in such a setting.

Consistent with previous epidemiological studies in the community, our study found that the prevalence of poor sleep quality was higher in older participants \[[@pone.0232834.ref009],[@pone.0232834.ref040]\]. However, the findings of studies on the association between sleep quality and gender were conflicting. Many studies indicate that females are more prone than males to experience poor sleep quality because a higher proportion of females have lower socioeconomic status and are more susceptible to anxiety and depression \[[@pone.0232834.ref040],[@pone.0232834.ref041]\]. In contrast, some studies indicate that males were more likely to report sleep problems than females \[[@pone.0232834.ref042],[@pone.0232834.ref043]\]. In our study, no significant difference in prevalence was observed between males and females, which is consistent with the findings of a study conducted among elderly attendees of a primary care centre in Malaysia \[[@pone.0232834.ref043]\] and the findings of another study conducted in nursing homes in Taiwan \[[@pone.0232834.ref034]\]. The differences in these findings may be related to the differences in the study sample and research location. Specific chronic conditions, such as hypertension \[[@pone.0232834.ref044]\], heart disease \[[@pone.0232834.ref045]\], arthritis \[[@pone.0232834.ref009]\] and COPD \[[@pone.0232834.ref008]\], were found to be associated with poor sleep quality. In our current study, one interesting finding is that the risk of poor sleep quality was increased with an increasing number of chronic diseases. This result is in accordance with those of other previous studies. For example, a cross-sectional study performed among 16,680 residents aged 65 years in eight low- and middle-income countries demonstrated that poor health and a high number of comorbidities were associated with more sleep complaints \[[@pone.0232834.ref046]\]. Also, another population-based cross-sectional study among 5,107 adults in Japan suggested that sleep quality was directly proportional to the number of comorbid conditions in a subject \[[@pone.0232834.ref047]\]. Thus, the mechanism underlying the association between multiple chronic conditions and poor sleep quality requires investigation to find ways for improving sleep quality among the elderly with at least one chronic disease.

Additionally, like in the previous studies \[[@pone.0232834.ref048]--[@pone.0232834.ref050]\], this study found that depression and anxiety symptoms independently increased the risk of poor sleep quality. Similarly, Cho HJ et al \[[@pone.0232834.ref051]\] found that a greater level of depressive symptoms had increased odds of sleep latency (≥1 hour) among 3,051 participants aged 67 and older in the United States of America (USA). Moreover, another study conducted among 2,040 elderly Koreans suggested that poor subjective sleep quality, longer sleep latency and frequent use of sleeping medication were independently associated with depression \[[@pone.0232834.ref052]\]. Also, Potvin et al \[[@pone.0232834.ref053]\] suggested that daytime sleepiness and sleep disturbances were significantly associated with anxiety. In addition, Press et al \[[@pone.0232834.ref054]\] reported that depressive symptoms were associated with decreased sleep satisfaction, while anxiety symptoms were associated with difficulty in falling asleep, waking up during the night and morning weakness. Therefore, these findings suggest that reducing depressive and anxiety symptoms in the elderly may help improve sleep quality.

Further, in this study, investigations on additive interactions of risk factors for sleep quality found that anxiety symptoms had additive interactions with older age, and chronic disease. That is, participants who had anxiety symptoms and older age, or anxiety symptoms and chronic disease were more likely to have poor sleep quality than those with anxiety symptoms and aged between 60 and 69, or anxiety symptoms and without chronic disease, respectively. This is in line with the findings of some previous studies that anxiety symptoms were more common among older people \[[@pone.0232834.ref055],[@pone.0232834.ref056]\], and chronic diseases and anxiety symptoms occurred contemporaneously among the elderly \[[@pone.0232834.ref057],[@pone.0232834.ref058]\]. These results, therefore, may partly be the reason for the occurrence of the foregoing interactions, which provide new insights into the prevention and treatment of sleep problems among the elderly.

We assessed social support using the SSRS, which is a self-rated questionnaire developed by Xiao and widely used in epidemiological studies in China. This perceived social support scale evaluates social relationships with friends, neighbours, colleagues and family members as well as the availability of functional support. Many studies consider social support to be an important factor in the maintenance of health status. Considering social support and sleep quality, this study found that lower level of social support increased the risk of poor sleep quality among the elderly in the nursing homes. This result was consistent with the findings of previous studies \[[@pone.0232834.ref059]--[@pone.0232834.ref061]\]. Specifically, Kishimoto et al \[[@pone.0232834.ref060]\] found that individuals with weak social support from spouses or family members were at a higher risk of sleep disturbances than their counterparts with strong social support. In addition, lower level of emotional social support was associated with more difficulties in initiating and maintaining sleep among the 998 elderly African-Americans \[[@pone.0232834.ref061]\]. In this regard, evidence has shown that social support may influence sleep quality by enabling a feeling of belonging, and protection from social isolation and negative emotions (e.g., loneliness, depression and anxiety), thus decreasing the incident risk of sleep disorders \[[@pone.0232834.ref062]--[@pone.0232834.ref064]\]. Therefore, improving social support among the elderly is a necessary cause in the prevention of sleeping problems among the elderly. Similar to our study results, people with anxiety had an increased risk of poor sleep quality, especially those with lower social support. Additionally, a stronger social network may contribute to individuals having multiple sources of health information, thus increasing the probability of obtaining information that may help maintain and promote healthy sleep behaviour \[[@pone.0232834.ref065],[@pone.0232834.ref066]\].

Quality of life is a comprehensive and multidimensional condition that refers to an individual's perceived physical and mental health under the influence of illness, injury and treatment over time. Obviously, sleep is an important influence factor for quality of life among Chinese elderly adults. It may provide a new perspective for us to improve quality of life among elderly in nursing homes due to sleep quality improvement.

To the best of our knowledge, this is the first study in China to explore the risk factors and their interactions for poor sleep quality among the elderly in nursing homes. Given the large population-based randomly selected sample, and the higher response rate, the findings of this study may provide valuable information for improving sleep quality among the aging populations in nursing homes. From a clinical point of view, concern about mental health in residents and intervention and treatment for anxiety symptoms may be helpful in the improvement of sleep quality in nursing homes. Additionally, the amelioration of the living environment and the provision of more social support were also important.

However, there are several limitations pertaining to this study that need to be highlighted. First, this study cannot establish a causal relationship between poor sleep quality and its associated risk factors due to the cross-sectional study design. For example, some studies also declared that poor sleep quality was positively associated with depression, anxiety and chronic diseases \[[@pone.0232834.ref067],[@pone.0232834.ref068]\]. Second, all data were measurements of self-rating, which may introduce recall bias in the findings. Third, the limited sensitivity and specificity of the Chinese version of PSQI may lead to misclassifications of poor sleepers. Finally, the findings may not be generalized to the elderly populations that are not living in nursing homes.

Conclusions {#sec018}
===========

The prevalence of poor sleep quality in nursing homes in China is relatively high. Its risk factors included older age, chronic diseases, depression symptoms, anxiety symptoms and lower social support. Besides, anxiety symptoms have additive interactions with age, chronic disease and social support for poor sleep quality. These findings have significant implications for interventions that aim to improve sleep quality among the elderly residents in nursing homes.

We thank all the elderly residents in the nursing homes who participated in this study for their cooperation.
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A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Stephan Doering, M.D.

Academic Editor

PLOS ONE

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#3: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: No

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#3: No

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: this study is good enough but it may need some improvement data such as more specific characteristic demography, analysis data, and explanation more about quality of life among Chinese elderly adults.

Reviewer \#3: This is a cross-sectional study examining in 817 elderly residents in nursing homes the prevalence of poor sleep quality and its risk factors

The study confirms a relatively high prevalence of poor sleep quality in nursing homes, previously reported. Anxiety symptoms had additive interactions with age, chronic disease and social support for

poor sleep quality.

On the whole, I have a quite positive opinion on this cross-sectional study. It has a quite large sample size and methods seem mostly accurate.

Major concerns:

1\. I understand but not completely agree on the reduction of scores of anxiety, depression and social support to categorical variables, using a cut off.

I ask to integrate the current analyses using the actual scores. Not necessarily, this request means a deletion of categorical classifications, but continuous variables should also be consider din the analyses

2\. Due to the number of comparisons performed, a significance level set al p\<0.05 should be adequately corrected for multiple comparisons

3\. Due to the potential effects of illumination levels in nursing homes on sleep-wake activity rhythms (e.g., Ancoli‐Israel et al. , 9: 373-379, 2000). I ask to collect (if possible) this information in the considered nursing homes and include this variable in their analyses

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: Yes: My Name is Elmeida Effendy, Psychiatrist (Consultant)

Reviewer \#3: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Author response to Decision Letter 1

16 Mar 2020

Response to \[PONE-D-19-31759R1\]

Thank you very much for your valuable comments and critiques, which have improved the clarity of our manuscript to a greater extent. Accordingly, we have thoroughly revised our manuscript based on the editors' and reviewers' comments and suggestions. The changes are highlighted in red for added words, or strikethrough for deleted words. Additionally, minor language, grammatical and stylistic errors have been corrected. Our specific point-by-point responses to the comments and queries have been addressed and itemized as follows:

Reviewer \#1: this study is good enough but it may need some improvement data such as more specific characteristic demography, analysis data, and explanation more about quality of life among Chinese elderly adults.

Answer: Thank you so much for your valuable comment. As suggested we have included and described more specific socio-demographic characteristics of the sample in relation to the study objectives. We did not dwell much on discussing quality of life of the elderly in the nursing homes because our main focus was on sleep quality, a component of quality life, and its associated factors. Thus, we justified why it was important to study this phenomenon. However, we agree that an explanation about the quality of life among the Chinese elderly people would highlight some insights in understanding some issues that would affect the living conditions of this population. Therefore, we have added a paragraph in the section of introduction to describe some facts about the quality of life of this group of people. Nevertheless, this study did not examine the quality of life of this population in general, but just a component of it, namely sleep quality. We thank you so much for your observation, which we have taken as a consideration to investigate the quality of life of this population in our future research.

Reviewer \#3: This is a cross-sectional study examining in 817 elderly residents in nursing homes the prevalence of poor sleep quality and its risk factors

The study confirms a relatively high prevalence of poor sleep quality in nursing homes, previously reported. Anxiety symptoms had additive interactions with age, chronic disease and social support for poor sleep quality.

On the whole, I have a quite positive opinion on this cross-sectional study. It has a quite large sample size and methods seem mostly accurate.

Major concerns:

1\. I understand but not completely agree on the reduction of scores of anxiety, depression and social support to categorical variables, using a cut off. I ask to integrate the current analyses using the actual scores. Not necessarily, this request means a deletion of categorical classifications, but continuous variables should also be consider din the analyses

Answer: Thank you so much for your valuable comment. It should be noted that the tools that we used to measure anxiety symptoms, depression symptoms and social support have high validity and reliability, and they are widely used to investigate anxiety, depression and social support among the Chinese elderly people. Besides, the cut-off points that we used on the total scores of these tools were adopted from other published studies on similar populations. However, according to the reviewer's suggestion, we tried to consider anxiety, depression and social support as continuous variables, but the results did not deviate much from those when anxiety, depression and social support were considered as categorical variables (see the Table 1 below). Essentially, the results in the Table 1 below mean pretty much the same thing as the results in our original analysis .

Table 1 Risk factors associated with poor sleep quality among the elderly in nursing homes

Variable B SE Wald AOR(95% CI)† P-value

Age (years)

60\~ 1.00

70\~ 0.58 0.25 5.15 1.78(1.08,2.92) 0.023

80\~ 0.98 0.24 17.37 2.67(1.68,4.24) \<0.001

Number of chronic diseases

0\~

1\~ 0.72 0.20 13.31 2.05(1.39,3.01) \<0.001

3\~ 0.86 0.27 10.01 2.35(1.39,4.00) 0.002

Depression symptoms 0.07 0.02 17.29 1.08(1.04,1.11) \<0.001

Anxiety symptoms 0.11 0.03 14.02 1.11(1.05,1.18) \<0.001

Social support -0.03 0.02 5.32 0.97(0.95,0.99) 0.021

2\. Due to the number of comparisons performed, a significance level set al p\<0.05 should be adequately corrected for multiple comparisons

Answer: Thank you so much for your valuable comment. A p\<0.025 was set to indicate significant results for multiple comparisons in this study.

3\. Due to the potential effects of illumination levels in nursing homes on sleep-wake activity rhythms (e.g., Ancoli‐Israel et al. , 9: 373-379, 2000). I ask to collect (if possible) this information in the considered nursing homes and include this variable in their analyses

Answer: Thank you so much for your valuable comment. We have not collected this information in our investigation; therefore we will consider this information in our further study.
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PONE-D-19-31759R2

Dear Dr. Xu,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Stephan Doering, M.D.

Academic Editor

PLOS ONE

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#3: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#3: No

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: the author has improved the data, there has been better writing in this article. This article will be more interest if you choose update references.

Reviewer \#3: The authors adequately responded to the points that I raised. It seems now acceptable for publication

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#3: No
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The prevalence of poor sleep quality and associated risk factors among Chinese elderly adults in nursing homes: a cross-sectional study

Dear Dr. Xu:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

For any other questions or concerns, please email <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Stephan Doering

Academic Editor

PLOS ONE
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